ADIPOQ rs2295236: Promoter Variation & Metabolic Traits
The genetic variant rs2295236 is a single-nucleotide polymorphism located in the 5′ regulatory promoter region of the human ADIPOQ gene on chromosome 3q27. In population genetic studies, regulatory variants within this locus have been investigated for their potential influence on circulating adiponectin concentrations and downstream markers of insulin sensitivity. However, the direct clinical evidence linking rs2295236 specifically to distinct metabolic endpoints remains limited, showing subtle regulatory trends rather than definitive health outcomes.
What each genotype means
Lower circulating adiponectin levels
Research indicates that individuals with this genotype may exhibit lower serum adiponectin levels compared to those carrying the T allele. Because adiponectin is involved in insulin sensitivity and metabolic regulation, these findings are often studied in the context of metabolic health, though results vary significantly across different global populations.
This genotype is common, though its prevalence varies significantly by ancestry.
Intermediate adiponectin profile
This genotype represents a heterozygous state where you carry one copy of each allele. Studies suggest that your circulating adiponectin levels may fall between those observed in individuals with the G/G and T/T genotypes, reflecting the complex and sometimes inconsistent associations between this variant and metabolic traits.
This is a frequently observed genotype across many diverse global populations.
Higher circulating adiponectin levels
Individuals with this genotype have been observed to have higher serum adiponectin levels in various studies. While adiponectin is associated with insulin sensitivity and anti-inflammatory processes, the clinical significance of this specific genotype remains a subject of ongoing research and may be influenced by other genetic and environmental factors.
This genotype is common, with frequencies varying by ethnic background.
What the SNP Is and Where It Sits
A single-nucleotide polymorphism (SNP) is a single-letter change at a specific genomic coordinate. The variant rs2295236 is positioned upstream of the coding sequence in the non-coding promoter region of the ADIPOQ gene. Because it does not alter the protein sequence of the hormone itself, it functions as a regulatory variant. Promoter regions contain docking sites for transcription factors—cellular machinery that dictates when, where, and how vigorously a gene is transcribed into messenger RNA (mRNA). Altering even a single nucleotide within these promoter motifs can subtly adjust transcription factor binding affinity, which may slightly tune overall expression rates of the gene in mature fat cells.
What the ADIPOQ Gene Does
The ADIPOQ gene provides instructions for making adiponectin, an abundant protein hormone (adipokine) synthesized and secreted primarily by adipocytes (fat cells). Unlike many other signaling molecules from fat tissue that increase with expanding fat mass, circulating adiponectin levels are generally lower in individuals with higher body mass index or excess visceral fat. Adiponectin plays a central role in maintaining energy balance: it stimulates glucose uptake, enhances fatty acid oxidation in skeletal muscle, and limits glucose output from the liver. Through these actions, adequate adiponectin signaling preserves systemic insulin sensitivity and supports cardiovascular and metabolic health.
Research Findings and Strength of Evidence
Genome-wide linkage studies early on highlighted chromosome 3q27—where ADIPOQ resides—as a major susceptibility hotspot for metabolic syndrome and altered glycemic traits. Subsequent association studies evaluated several regulatory promoter SNPs across the gene, noting that certain common promoter alleles modestly correlate with variations in baseline serum adiponectin and glycemic control. However, the evidence specifically surrounding rs2295236 remains classified as Limited. Metabolic traits are profoundly polygenic and strongly influenced by diet, physical activity, and total body composition. Individual promoter SNPs each contribute only a fraction of a percent of variance in circulating hormone levels, and study results across different geographic cohorts have frequently yielded mixed or modest associations.
Population Frequency and Global Distribution
The minor allele at rs2295236 is widely distributed across global populations, exhibiting an estimated minor allele frequency (MAF) ranging from roughly 0.30 to 0.45 across diverse ancestries. Because both the major and minor alleles are so common, heterozygous and homozygous genotypes are routinely observed across continental groups. This high level of background diversity is typical for non-coding regulatory variations in human metabolic genes, reflecting ancient evolutionary history rather than a recent, localized mutation.
What You Can and Cannot Do With This Information
Discovering your genotype at rs2295236 provides educational insight into common promoter variations that geneticists study in metabolic biology. However, it cannot diagnose insulin resistance, prediabetes, type 2 diabetes, or cardiovascular disease, nor can it predict them in isolation. Complex traits are shaped by hundreds of genetic loci working alongside lifestyle behaviors. Carrying a variant allele is not a medical diagnosis and should never prompt drastic changes in diet or self-medication. Any questions regarding insulin resistance, blood sugar monitoring, or prescribed medications should be reviewed with your primary healthcare provider or pharmacist.
How common is this variant?
The minor allele at rs2295236 is widely distributed across global populations, exhibiting an estimated minor allele frequency of roughly 0.30 to 0.45 across diverse ancestries.
Frequently asked questions
Does having the minor genotype mean I will develop diabetes?
No. Type 2 diabetes and insulin resistance are multifactorial conditions governed by hundreds of genetic variants alongside diet, sleep, stress, and physical exercise. The variant rs2295236 carries only limited scientific evidence and has a very small statistical association, meaning it cannot predict clinical disease on its own.
Can this genetic variant tell me my exact adiponectin blood level?
No. While promoter SNPs can modestly affect gene transcription, serum adiponectin levels are dynamic and heavily influenced by overall adiposity, diet, exercise, and metabolic state. Direct blood testing ordered by a medical professional is the only way to accurately measure circulating adiponectin or assess glycemic regulation.
Why is the evidence strength rated as "Limited"?
Genetic association studies often report modest statistical links between ADIPOQ promoter variants and metabolic biomarkers, but these findings frequently vary between ancestral cohorts and sample sizes. Without uniform, large-scale replication establishing a strong, direct causal mechanism, science catalogs classify the evidence as limited.
Should I change my diet or lifestyle based on my rs2295236 genotype?
No single genetic polymorphism warrants drastic dietary changes or supplement protocols. General evidence-based lifestyle habits—such as engaging in regular aerobic and resistance exercise, managing stress, and eating a balanced, nutrient-dense diet—support healthy adipokine production and insulin sensitivity regardless of your genotype.
Sources & further reading
Educational information only, last refreshed 9/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2295236?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ADIPOQ
Promoter variant (-11391G>A) in the ADIPOQ gene associated with circulating adiponectin levels.
This SNP is associated with circulating adiponectin levels and metabolic syndrome risk.
This SNP is studied for its role in adiponectin levels and metabolic response to diet.
This SNP in the adiponectin gene is associated with insulin sensitivity and metabolic syndrome risk.
A candidate SNP in the adiponectin gene investigated for its potential association with human longevity and aging phenotypes.
A variant in the ADIPOQ gene linked to inflammatory regulation and insulin sensitivity in the context of dietary intake.